Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes

V. Dudzevicius, N. Ghazal, R. Ineson, S. Muzaffar, G. Antunes, N. Krishnaraj, S. Murphy (Middlesbrough, United Kingdom)

Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Session: Treatment and outcome in hospitalised patients with community-acquired pneumonia
Session type: E-Communication Session
Number: 1844
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Dudzevicius, N. Ghazal, R. Ineson, S. Muzaffar, G. Antunes, N. Krishnaraj, S. Murphy (Middlesbrough, United Kingdom). Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes. Eur Respir J 2008; 32: Suppl. 52, 1844

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008



Impact of reducing antibiotic treatment on inflammation among patients with community-acquired pneumonia.
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Guideline-concordant therapy and outcomes in healthcare-associated pneumonia
Source: Eur Respir J 2011; 38: 878-887
Year: 2011



Potential protective role of prior to diagnosis antibiotic treatment in community-acquired pneumonia: Clinical presentation and outcomes
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011


Increasing outpatient treatment of mild community-acquired pneumonia: systematic review and meta-analysis
Source: Eur Respir J 2011; 37: 858-864
Year: 2011



An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Impact of neutrophil apoptosis on clinical outcomes in nonresponding community-acquired pneumonia
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010


The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012

Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients
Source: Eur Respir J 2011; 38: 643-648
Year: 2011



Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011

Adherence to guidelines and clinical stability in community-acquired pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004

Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2012; 39: 156-162
Year: 2012



Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2011; 39: 156-162
Year: 2012



Impact of host status, bacteria and antibiotic therapy on systemic inflammatory response syndrome (SIRS) development in community-acquired pneumonia (CAP)
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines
Source: Eur Respir J 2003 Dec 01;22(6):876-882
Year: 2003



Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer
Source: Eur Respir Rev 2008; 17: 83-85
Year: 2008



Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015



Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008

Impact of guidelines on HAP and VAP outcomes
Source: Eur Respir Mon 2011; 53: 66-73
Year: 2011